David Gee - Cellebrite Chief Officer
| CLBTWDelisted Stock | USD 5.15 0.44 7.87% |
Executive
David Gee is Chief Officer of Cellebrite DI Equity
| Age | 57 |
| Phone | 972 73 394 8000 |
| Web | https://www.cellebrite.com |
Cellebrite Management Efficiency
The company has return on total asset (ROA) of 0.0639 % which means that it generated a profit of $0.0639 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (17.6851) %, meaning that it generated substantial loss on money invested by shareholders. Cellebrite's management efficiency ratios could be used to measure how well Cellebrite manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Steve Peterson | Usio Inc | N/A | |
| Petra Pesendorfer | Valneva SE ADR | 38 | |
| Paul Manley | Usio Inc | N/A | |
| Jennifer Settles | U Haul Holding | N/A | |
| Jeff Hoover | Alta Equipment Group | N/A | |
| Joe CPP | Usio Inc | N/A | |
| Susanne EderLingelbach | Valneva SE ADR | N/A | |
| Christian Taucher | Valneva SE ADR | N/A | |
| Franck MBA | Valneva SE ADR | 57 | |
| Anthony CPA | Alta Equipment Group | 46 | |
| Dipal Patel | Valneva SE ADR | 49 | |
| Joshua Drumm | Valneva SE ADR | N/A | |
| Frederic Jacotot | Valneva SE ADR | 60 | |
| Kristine Campbell | U Haul Holding | 48 | |
| Paul Ivankovics | Alta Equipment Group | N/A | |
| MD MBA | U Haul Holding | 46 | |
| Jason Berg | U Haul Holding | 51 | |
| Silas Green | Usio Inc | N/A | |
| Maria Bell | U Haul Holding | 53 | |
| Peter Buhler | Valneva SE ADR | 53 | |
| Hanneke Schuitemaker | Valneva SE ADR | N/A | |
Management Performance
| Return On Equity | -17.69 | |||
| Return On Asset | 0.0639 |
Cellebrite DI Equity Leadership Team
Elected by the shareholders, the Cellebrite's board of directors comprises two types of representatives: Cellebrite inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cellebrite. The board's role is to monitor Cellebrite's management team and ensure that shareholders' interests are well served. Cellebrite's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cellebrite's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Yossi Carmil, CEO Director | ||
| Thomas Hogan, Executive Chairman | ||
| Zohar TadmorEilat, Chief Officer | ||
| Osnat Tirosh, Chief Officer | ||
| Ori Nurick, Ex Management | ||
| David Gee, Chief Officer | ||
| Adam Jaffe, VP Communications | ||
| Ayala Shapira, General Counsel | ||
| Anat Paran, Executive Services | ||
| Marque Teegardin, President Management | ||
| Ronnen Armon, Chief Officer | ||
| Arnon Zilberman, Executive Operations | ||
| Andrew Kramer, Vice Relations | ||
| Dana Gerner, Chief Officer | ||
| Paul Battaglia, Sr America | ||
| Alon Klomek, Chief Officer | ||
| Lisa Cole, Chief Officer | ||
| Leeor BenPeretz, Chief Officer | ||
| Mark Gambill, Chief Officer | ||
| Marcus Jewell, Global Officer |
Cellebrite Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Cellebrite a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -17.69 | |||
| Return On Asset | 0.0639 | |||
| Profit Margin | (0.29) % | |||
| Operating Margin | 0.13 % | |||
| Number Of Shares Shorted | 356.81 K | |||
| Price To Earning | 12.50 X | |||
| Revenue | 325.11 M | |||
| Gross Profit | 219.91 M | |||
| EBITDA | 43.29 M | |||
| Net Income | (81.1 M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Other Consideration for investing in Cellebrite Stock
If you are still planning to invest in Cellebrite DI Equity check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cellebrite's history and understand the potential risks before investing.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Transaction History View history of all your transactions and understand their impact on performance |